Skip to main content

Greenberg Traurig advises PlusDental shareholders on exit to medical devices company Straumann

Greenberg Traurig advised shareholders of health-tech start-up PlusDental on the sale to Straumann Group. The global manufacturer of dental replacement and orthodontic solutions has acquired 100 percent of the shares in Berlin-based PlusDental for a purchase price of approximately 135 million Swiss Francs. Merger clearance has been obtained, and the transaction has been completed.

PlusDental has branches in several European countries and is a leading provider of clear aligner treatments under close medical supervision. With additional market coverage in countries such as the Netherlands, Sweden and the UK, PlusDental expands the presence of Straumann Group in the medically supervised consumer orthodontics segment.

Background: Greenberg Traurig comprehensively advised shareholders of PlusDental consisting of strategic investors, private equity and venture capital investors as well as business angels on all legal aspects of the transaction. Cartel clearance was handled by special counsel.

About Greenberg Traurig: Greenberg Traurig, LLP has more than 2400 attorneys in 42 locations in the United States, Europe, Latin America, Asia, and the Middle East. The firm, often recognized for its focus on philanthropic giving, innovation, diversity, and pro bono, reported gross revenue of over $2 Billion for FY 2021. The firm is consistently among the top firms on the Am Law 100, Am Law Global 100, NLJ 250, and Law360 (US) 400. On the debut 2022 Law360 Pulse Leaderboard, it is a Top 15 firm. Greenberg Traurig is Mansfield Rule 4.0 Certified Plus by The Diversity Lab and net carbon neutral with respect to its office energy usage. Web: